Tirza Injection 2.5 mg/0.5 ml contains Tirzepatide, a novel once-weekly injectable medication used for the management of type 2 diabetes mellitus and weight-related metabolic conditions. It is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that helps improve blood sugar control and support weight reduction when used along with diet and exercise.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Tirza Injection is indicated for:

• Type 2 diabetes mellitus (as an adjunct to diet and exercise)
• Improvement of glycemic control in adults with inadequate response to oral antidiabetic agents
• Weight management in obese or overweight patients (as per physician guidance)

Mechanism of Action

Tirzepatide works through dual incretin receptor activation:

• GLP-1 receptor activation: Increases insulin secretion, reduces glucagon levels, slows gastric emptying, and enhances satiety
• GIP receptor activation: Improves insulin sensitivity and glucose metabolism

Together, these effects lead to:

• Better blood sugar control
• Reduced appetite and calorie intake
• Support for gradual weight reduction

Dosage and Administration

• Administered as a subcutaneous injection once weekly
• The usual starting dose is 2.5 mg once weekly, which may be increased gradually under medical supervision
• Inject into the abdomen, thigh, or upper arm
• Rotate injection sites to reduce irritation
• Follow a consistent weekly schedule

Benefits

• Improves long-term blood glucose control
• Supports weight reduction in overweight and obese patients
• Reduces appetite and food intake
• Convenient once-weekly dosing
• Helps improve metabolic health markers

Side Effects

Common side effects may include:

• Nausea
• Vomiting
• Diarrhea or constipation
• Decreased appetite
• Abdominal discomfort

Less common but serious side effects:

• Pancreatitis
• Gallbladder disease
• Hypoglycemia (especially with other antidiabetic drugs)
• Kidney function changes due to dehydration

Precautions and Warnings

• Not recommended for patients with type 1 diabetes
• Use cautiously in patients with a history of pancreatitis
• May cause dehydration; maintain adequate fluid intake
• Not recommended during pregnancy or breastfeeding unless advised by a physician
• Regular monitoring of blood glucose is required
• Dose escalation must be gradual under medical supervision

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Drug Interactions

Tirza Injection may interact with:

• Insulin or sulfonylureas (increased risk of hypoglycemia)
• Other antidiabetic medications
• Drugs affecting gastrointestinal motility

Always inform your doctor about all medications being used.

Storage

• Store in a refrigerator at 2°C to 8°C
• Do not freeze
• Protect from light
• Keep out of reach of children.